JAK Inhibitors Show Promise for Treatment-Resistant Rheumatoid Arthritis
New research identifies key factors behind difficult-to-treat RA and highlights JAK inhibitors as promising therapy option.
Autoimmune disorders, rheumatoid arthritis, systemic inflammation, and immune dysregulation
206 articles
New research identifies key factors behind difficult-to-treat RA and highlights JAK inhibitors as promising therapy option.
New research reveals exercise and lifestyle changes outperform anti-inflammatory drugs for managing chronic pain in RA patients.
New research reveals that rheumatoid arthritis patients on JAK inhibitor drugs show impaired immune responses to the shingles vaccine.
Scientists discover how protective immune cells in brain membranes lose their strength during Alzheimer's progression.
Researchers identify how TSLP protein creates regulatory T cells that suppress immune responses in melanoma.
Scientists discover transitional dendritic cells that regulate immune responses, offering new targets for cancer therapy.
Regulatory T cells persist in brain tissue after inflammation, using CD38 to maintain immune control and prevent autoimmune relapses.
New research reveals how SIRT2 regulates T cell responses, potentially improving cancer immunotherapy and immune function.
New research reveals how specialized immune cells use IL-4 to kickstart robust CD8 T cell responses against malaria infection.
Scientists discover serotonin's role in making cancer treatments less effective, opening new therapeutic possibilities.
Scientists discover tumor-associated immune cells can promote nerve growth and dramatically improve spinal cord injury recovery.
New research reveals how granzyme A protein targets specific cells for pyroptosis, a form of programmed cell death crucial for immune defense.